This does seem somewhat odd, though not completly out f the realm of practice. Normally pharma companies have to pay hospitals to enroll patients in clinical trials. There is a lot of additional record keeping and montoring that is expensive. Two trials that I am watching on chemoprevention are actually paying patients to enroll, paying for the drugs, and paying the institutions that are doing the trials. If the patients had to accept the financial burden of the trial, nothing would ever get done in the world of new drug development. So I find this far from the norm. For myself I would have no issues calling Introgen Theraputics and finding out what their protocol for hospital participation is, are they or are they not paying the hospitals to do the trial, and if they are, my next call would be to the hospital administrator to find out what the deal is.... double dipping?

Brian, stage 4 oral cancer survivor. OCF Founder and Director. The first responsibility of a leader is to define reality. The last is to say thank you. In between, the leader is a servant.